In male obesity, especially in the context of type 2 diabetes (T2D), numerous other factors contribute towards the development of CH that include enhanced conversion of testosterone to oestradiol within adipose tissue from enhanced aromatase activity [86], and consequent central suppressive effects of oestradiol on the HPG axis. The gene discussed is CYP19A1; the disease is type 2 diabetes mellitus.